The Enterprise Value as of November 2024 (TTM) for Castle Biosciences, Inc. (CSTL) is 787.96M

According to Castle Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 787.96M. This represents a change of 36.76% compared to the average of 576.16M of the last 4 quarters.

Castle Biosciences, Inc. (CSTL) Historical Enterprise Value (quarterly & annually)

How has CSTL Enterprise Value performed in the past?

The mean historical Enterprise Value of Castle Biosciences, Inc. over the last ten years is 473.13M. The current 787.96M Enterprise Value has changed 16.55% with respect to the historical average. Over the past ten years (40 quarters), CSTL's Enterprise Value was at its highest in in the June 2021 quarter at 1.47B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Castle Biosciences, Inc. (CSTL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Castle Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Castle Biosciences, Inc. (CSTL) Average Enterprise Value

How has CSTL Enterprise Value performed in the past?

The current Enterprise Value of Castle Biosciences, Inc. (CSTL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Castle Biosciences, Inc. (CSTL) Enterprise Value vs. Peers

How is CSTL’s Enterprise Value compared to its peers?

Castle Biosciences, Inc.’s Enterprise Value is less than CareDx, Inc (1.28B), less than Twist Bioscience Corporation (2.61B), greater than Biodesix, Inc. (239.30M), less than Natera, Inc. (21.80B), greater than Genetron Holdings Limited (0), less than Olink Holding AB (publ) (3.16B), greater than FONAR Corporation (90.15M), greater than Exagen Inc. (70.73M), greater than Personalis, Inc. (223.32M), less than Guardant Health, Inc. (4.90B), greater than Burning Rock Biotech Limited (-109478162.72), greater than Sera Prognostics, Inc. (209.68M), greater than LumiraDx Limited (301.24M), greater than Neuronetics, Inc. (56.78M), greater than Enzo Biochem, Inc. (5.47M),

Build a custom stock screener for Castle Biosciences, Inc. (CSTL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Castle Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Castle Biosciences, Inc. (CSTL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Castle Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.